Case of acute drug-induced hepatitis after halothane anesthesia

The aim of publication. To present the case of severe acute drug-induced hepatitis after halothane anesthesia in relation to significance of allergies history preoperative inquiry and assessment of medical management of patients, using modern prognostic scales.Key points. Biotransformation of volati...

Full description

Saved in:
Bibliographic Details
Main Authors: I. Yu. Pirogova, Ye. V. Berestova, O. Yu. Bastrikov, Ye. B. Kovaleva, T. P. Petukhova, M. V. Guseva, I. A. Gubina, I. V. Rezepin, S. P. Sinitsyn
Format: Article
Language:Russian
Published: Gastro LLC 2013-05-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/1192
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860233499312128
author I. Yu. Pirogova
Ye. V. Berestova
O. Yu. Bastrikov
Ye. B. Kovaleva
T. P. Petukhova
M. V. Guseva
I. A. Gubina
I. V. Rezepin
S. P. Sinitsyn
author_facet I. Yu. Pirogova
Ye. V. Berestova
O. Yu. Bastrikov
Ye. B. Kovaleva
T. P. Petukhova
M. V. Guseva
I. A. Gubina
I. V. Rezepin
S. P. Sinitsyn
author_sort I. Yu. Pirogova
collection DOAJ
description The aim of publication. To present the case of severe acute drug-induced hepatitis after halothane anesthesia in relation to significance of allergies history preoperative inquiry and assessment of medical management of patients, using modern prognostic scales.Key points. Biotransformation of volatile anesthetics can result in production of toxic metabolites and metabolic by-products, resulting in damage of the liver and kidneys. Disorders of liver function can be of two types: early – transient elevation of transaminase activity and late – liver necrosis. Mortality rate at the latter reaches 50–80%. In presented clinical case both variants developed in the same patient in different terms are described. Despite of acute drug-induced hepatitis with severe liver failure, complex treatment resulted in favorable outcome, including the remote-terms result.Conclusion. The most important factors determining favorable prognosis at drug-induced liver disease, include adequate doses of glucocorticosteroids, application of MARS-therapy and absence of background liver disease. Application of differential diagnostics algorithms and prognostic scales at drug-induced liver disease helps clinician to choose proper treatment approach at specific stage.
format Article
id doaj-art-d0d77738a8674fc99f594d435aaf976d
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2013-05-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-d0d77738a8674fc99f594d435aaf976d2025-02-10T16:14:32ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732013-05-012323640776Case of acute drug-induced hepatitis after halothane anesthesiaI. Yu. Pirogova0Ye. V. Berestova1O. Yu. Bastrikov2Ye. B. Kovaleva3T. P. Petukhova4M. V. Guseva5I. A. Gubina6I. V. Rezepin7S. P. Sinitsyn8State educational government-financed institution of higher professional education «Chelyabinsk state medical academy»Municipal healthcare institution, city clinical hospital N 8State educational government-financed institution of higher professional education «Chelyabinsk state medical academy»Municipal healthcare institution, city clinical hospital N 3Municipal healthcare institution, city clinical hospital N 3Municipal healthcare institution, city clinical hospital N 8Municipal healthcare institution, city clinical hospital N 8Municipal healthcare institution, city clinical hospital N 3State educational government-financed institution of higher professional education «Chelyabinsk state medical academy»The aim of publication. To present the case of severe acute drug-induced hepatitis after halothane anesthesia in relation to significance of allergies history preoperative inquiry and assessment of medical management of patients, using modern prognostic scales.Key points. Biotransformation of volatile anesthetics can result in production of toxic metabolites and metabolic by-products, resulting in damage of the liver and kidneys. Disorders of liver function can be of two types: early – transient elevation of transaminase activity and late – liver necrosis. Mortality rate at the latter reaches 50–80%. In presented clinical case both variants developed in the same patient in different terms are described. Despite of acute drug-induced hepatitis with severe liver failure, complex treatment resulted in favorable outcome, including the remote-terms result.Conclusion. The most important factors determining favorable prognosis at drug-induced liver disease, include adequate doses of glucocorticosteroids, application of MARS-therapy and absence of background liver disease. Application of differential diagnostics algorithms and prognostic scales at drug-induced liver disease helps clinician to choose proper treatment approach at specific stage.https://www.gastro-j.ru/jour/article/view/1192acute drug-induced hepatitishalothane anesthesia
spellingShingle I. Yu. Pirogova
Ye. V. Berestova
O. Yu. Bastrikov
Ye. B. Kovaleva
T. P. Petukhova
M. V. Guseva
I. A. Gubina
I. V. Rezepin
S. P. Sinitsyn
Case of acute drug-induced hepatitis after halothane anesthesia
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
acute drug-induced hepatitis
halothane anesthesia
title Case of acute drug-induced hepatitis after halothane anesthesia
title_full Case of acute drug-induced hepatitis after halothane anesthesia
title_fullStr Case of acute drug-induced hepatitis after halothane anesthesia
title_full_unstemmed Case of acute drug-induced hepatitis after halothane anesthesia
title_short Case of acute drug-induced hepatitis after halothane anesthesia
title_sort case of acute drug induced hepatitis after halothane anesthesia
topic acute drug-induced hepatitis
halothane anesthesia
url https://www.gastro-j.ru/jour/article/view/1192
work_keys_str_mv AT iyupirogova caseofacutedruginducedhepatitisafterhalothaneanesthesia
AT yevberestova caseofacutedruginducedhepatitisafterhalothaneanesthesia
AT oyubastrikov caseofacutedruginducedhepatitisafterhalothaneanesthesia
AT yebkovaleva caseofacutedruginducedhepatitisafterhalothaneanesthesia
AT tppetukhova caseofacutedruginducedhepatitisafterhalothaneanesthesia
AT mvguseva caseofacutedruginducedhepatitisafterhalothaneanesthesia
AT iagubina caseofacutedruginducedhepatitisafterhalothaneanesthesia
AT ivrezepin caseofacutedruginducedhepatitisafterhalothaneanesthesia
AT spsinitsyn caseofacutedruginducedhepatitisafterhalothaneanesthesia